Betapace and Ventricular Extrasystoles

This page shows results related to Betapace and Ventricular Extrasystoles from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Betapace and Ventricular Extrasystoles

Age

>60 Years	20
40-49 Years	2

Gender

Male: 46%
Female: 54%

Outcome

What were the most common outcomes of those reporting Ventricular Extrasystoles?

Hospitalization	19
Other	14
Life Threatening	8
Death	2

Reporter

Who most commonly reported Ventricular Extrasystoles?

Physician	13
Other	5
Consumer	3
Pharmacist	1

Therapy

Of those reporting Ventricular Extrasystoles, why were they taking Betapace?

Atrial Fibrillation	9
Drug Use For Unknown Indication	3
Supraventricular Tachycardia	2
Arrhythmia	2
Haemothorax	1

Other Medications

Which medications reported to the FDA are most commonly associated with Ventricular Extrasystoles?

Vioxx	1017
Fosamax	517
Digoxin	370
Zometa	213
Aredia	212
	Show More
Accutane	194
Activase	88
Rebif	82
Avonex	81
Diovan	74
Lyrica	73
Aspirin	64
Remicade	64
Risperdal	63
Gilenya	61
Avandia	59
Cymbalta	57
Seroquel	53
Alendronate Sodium	52
Nuvaring	52
Clozaril	52
Lipitor	48
Cordarone	46
Zyprexa	46
Zelnorm	46
Coricidin Hbp Cough + Cold (chlorph...	45
Amiodarone Hcl	45
Tasigna	44
Forteo	43
Avastin	43
Revlimid	42
Propofol	42
Celebrex	42
Herceptin	40
Strattera	40
Betaseron	40
Fosamax Plus D	40
Avelox	38
Velcade	37
Escitalopram	36
Byetta	35
Crestor	35
Sevoflurane	34
Humira	34
Furosemide	34
Synthroid	33
Fluorouracil	33
Enbrel	32
Metoprolol Succinate	32
Multaq	32
Gleevec	31

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Betapace, view the complete Betapace adverse event report.

Scientific Publications on Ventricular Extrasystoles

Comments

Share your experience with Betapace and Ventricular Extrasystoles.